Особенности клинического течения бронхопневмонии при постковидном синдроме у детей

Дилором Кенжаева; Рушания Пулатова

doi:10.47689/2181-3663-vol4-iss4-pp110-118

Dilorom Kenjaeva Department of pediatrics in propaedeutics of children’s diseases, children’s diseases and family medicine, Tashkent State Medical University Termez Branch
Rushaniya Pulatova Department of pediatrics in propaedeutics of children’s diseases, children’s diseases and family medicine, Tashkent State Medical University Termez Branch

DOI

https://doi.org/10.47689/2181-3663-vol4-iss4-pp110-118

Keywords

post-COVID syndrome , children , bronchopneumonia , clinical course

Abstract

Recent literature has reported isolated cases of the clinical course of post-COVID syndrome in children, including multiple organ involvement, autoimmune lesions, and pronounced changes in the immune system. The long-term consequences of coronavirus infection in children remain poorly studied.

Objective: To investigate the clinical features of bronchopneumonia in post-COVID syndrome in children.

Materials and methods: We observed 179 patients: 61 with "long COVID" (symptom duration more than 4 but less than 12 weeks), 68 with CPS (chronic post-COVID syndrome; over 12 weeks from disease onset according to ICD-10), and 50 children with CAP (community-acquired pneumonia) of unknown etiology aged 1 to 12 years. All children were admitted to the Termez City Children's Medical Center with bronchopneumonia and hospitalized in the pulmonology department and ICU. ELISA for S-RBD SARS-CoV-2 IgG was considered positive at a value > 1 IU/ml.

Results and discussion: Bronchopneumonia in long COVID mainly presented with moderate severity, dyspnea, subcostal retractions during breathing, and often a segmental form of bronchopneumonia was diagnosed. CPS was characterized by a high frequency of severe bronchopneumonia, central cyanosis, severe respiratory failure (head bobbing), pronounced signs of CNS intoxication (temperature decrease to 35°C and below, increased pulse rate), and was often diagnosed as interstitial pneumonia. Prolonged manifestation of CPS was ultimately characterized by autoimmune pathology and juvenile rheumatoid arthritis, gastrointestinal diseases and diarrhea, Guillain-Barré syndrome, and polyradiculoneuropathy. In long COVID, the development of a septic process with generalized damage to various organs and systems and Stevens-Johnson syndrome was noted.

References

Belhadjer Z., Meot M., Bajolle F. et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020; 142(5): 429–36. https://dx.doi.org/10.1161/CIRCULATIONAHA.120.048360.

Bobomuratov T.A, Karimova N.A, Tursunbayev A.K, Nurmatova N.F. Complications from the cardiovascular system in children who have had COVID-19./ E3S Web of Conferences.- 2023 |Conference paper. DOI:10.1051/e3sconf/202338101092

Esper F., Shapiro E.D., Weibel C.et al. Association between a novel human coronavirus and Kawasaki disease /J. Infect Dis. – 2005. – V. 191. – P. 499-502.

Gomes, S Gonzales Martinez et al. //Lancet. – 2020. – V. 23. – P. 395(10237). – P. 1607-1608.

Hennon T.R., Penque M.D., Aziz R.A. et al. COVID-19 associated Multisystem In- flammatory Syndrome in Children (MIS-C) guide- lines; a Western New York approach / //Prog. Pedi- atr. Cardiol. – 2020. 23:101232. Epub ahead of print. doi: 10.1016/j.ppedcard.2020.101232.

Kantemirova M.G., Novikova Yu.Yu., Ovsyannikov D.Yu. Pediatric pharmacology 17(3), 219–229 (2020). doi: 10.15690/pf.v17i3.2126

Verdoni L., Mazza A., Gervasoni A. et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: An observational cohort study. Lancet. 2020; 395(10239): 1771–78. https://dx.doi.org/10.1016/S0140-6736(20)31103-X.

Whitaker E., Bamford A., Kenny J. et al. //JAMA. Publishtd online June 8 2020 doi 10.1001/ ja- ma.2020.10369

Whittaker E., Bamford A., Kenny J. et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020; 324(3): 259–69. https://dx.doi.org/10.1001/jama.2020.10369.

Абатуров А.Е., Агафонова Е.А., Кривуша Е.Л., Никулина А.А. Патогенез COVID-19 / Zdorov‘e Rebenka. – 2020. – №15 (2). – P. 133-144.

Зайратьянц О.В., Самсонова М.В., Михалева Л.М. и др. Патологическая анатомия COVID-19 /Атлас /Под общ. ред. О. В. Зайратьянца. – М.: ДЗМ, 2020. – 116 с.

Зверева Н.Н., Сайфуллин М.А., Ртищев А.Ю. и др. Коронавирусная инфекция у детей / //Педиатрия. – 2020. – №99 (2). – С. 270-278.

Намазова-Баранова Л. С. Короновирусная инфекция (COVID-19) у детей (состояние на апрель 2020) //Педиатрическая фармакология. – 2020. – Т. 17. – №2. – С. 93-94.

Downloads

PDF (Русский)

24 7

Published

2025-10-20

How to Cite

Kenjaeva, D. and Pulatova, R. 2025. Characteristics of the clinical course of bronchopneumonia in post-COVID syndrome in children. Preventive Medicine and Health. 4, 4 (Oct. 2025), 110–118. DOI:https://doi.org/10.47689/2181-3663-vol4-iss4-pp110-118.